Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
CD226 ligation protects against EAE by promoting IL-10 expression via regulation of CD4+ T cell differentiation.
The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis.
Neuro-Ophthalmic Syndromes and Processing Speed in Multiple Sclerosis.
Profile of Differential Promoter Activity by Nucleotide Substitution at GWAS Signals For Multiple Sclerosis.
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
Health related quality of life in patients recently diagnosed with multiple sclerosis.
Multiple sclerosis: Lessons from molecular neuropathology.
Validity and reliability of the Greek version of the Modified Fatigue Impact Scale in multiple sclerosis patients.
Regulation of Experimental Autoimmune Encephalomyelitis by TPL-2 Kinase.
Recruitment of participants to a multiple sclerosis trial: The CombiRx experience.
The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
The top clinical trial opportunities in therapeutic apheresis and neurology.
Proteasome Inhibitors: A New Perspective for Treating Autoimmune Diseases.
Multi-slice myelin water imaging for practical clinical applications at 3.0 T.
The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: Evidence for the involvement of astrocytes.
Automated detection of white matter and cortical lesions in early stages of multiple sclerosis.
Longitudinal fMRI studies: Exploring brain plasticity and repair in MS.
Strategies for regeneration of components of nervous system: scaffolds, cells and biomolecules.
The Standards of Reporting of Neurological Disorders (STROND) checklist: Application to multiple sclerosis.
Potential anti-tumor effects of FTY720 associated with PP2A activation: a brief review.
Recent achievements in stem cell-mediated myelin repair.
Ion Channels in Neurological Disorders.
Disease-modifying therapies and infectious risks in multiple sclerosis.
Enabling Precision Medicine With Digital Case Classification at the Point-of-Care.
Pages
« first
‹ previous
…
381
382
383
384
385
386
387
388
389
…
next ›
last »